FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913202387> ?p ?o ?g. }

• W2913202387 endingPage "e0211888" @default.
• W2913202387 startingPage "e0211888" @default.
• W2913202387 abstract "Empiric antibiotic therapy for suspected hematogenous vertebral osteomyelitis (HVO) should be initiated immediately in seriously ill patients and may be required in those with negative microbiological results. The aim of this study was to inform the appropriate selection of empiric antibiotic regimens for the treatment of suspected HVO by analyzing antimicrobial susceptibility of isolated bacteria from microbiologically proven HVO.We conducted a retrospective chart review of adult patients with microbiologically proven HVO in five tertiary-care hospitals over a 7-year period. The appropriateness of empiric antibiotic regimens was assessed based on the antibiotic susceptibility profiles of isolated bacteria.In total, 358 cases of microbiologically proven HVO were identified. The main causative pathogens identified were methicillin-susceptible Staphylococcus aureus (33.5%), followed by methicillin-resistant S. aureus (MRSA) (24.9%), Enterobacteriaceae (19.3%), and Streptococcus species (11.7%). Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae and anaerobes accounted for only 1.7% and 1.4%, respectively, of the causative pathogens. Overall, 73.5% of isolated pathogens were susceptible to levofloxacin plus rifampicin, 71.2% to levofloxacin plus clindamycin, and 64.5% to amoxicillin-clavulanate plus ciprofloxacin. The susceptibility to these oral combinations was lower in cases of healthcare-associated HVO (52.6%, 49.6%, and 37.6%, respectively) than in cases of community-acquired HVO (85.8%, 84.0%, and 80.4%, respectively). Vancomycin combined with ciprofloxacin, ceftriaxone, ceftazidime, or cefepime was similarly appropriate (susceptibility rates of 93.0%, 94.1%, 95.8%, and 95.8%, respectively).Based on our susceptibility data, vancomycin combined with a broad-spectrum cephalosporin or fluoroquinolone may be appropriate for empiric treatment of HVO. Fluoroquinolone-based oral combinations may be not appropriate due to frequent resistance to these agents, especially in cases of healthcare-associated HVO." @default.
• W2913202387 created "2019-02-21" @default.
• W2913202387 creator A5001455617 @default.
• W2913202387 creator A5002973930 @default.
• W2913202387 creator A5005473429 @default.
• W2913202387 creator A5008696378 @default.
• W2913202387 creator A5010143623 @default.
• W2913202387 creator A5011578742 @default.
• W2913202387 creator A5016033592 @default.
• W2913202387 creator A5025487051 @default.
• W2913202387 creator A5033799485 @default.
• W2913202387 creator A5061810491 @default.
• W2913202387 creator A5067286446 @default.
• W2913202387 creator A5069788866 @default.
• W2913202387 creator A5072574087 @default.
• W2913202387 creator A5077402434 @default.
• W2913202387 creator A5080555312 @default.
• W2913202387 creator A5084708203 @default.
• W2913202387 creator A5086479486 @default.
• W2913202387 date "2019-02-08" @default.
• W2913202387 modified "2023-10-13" @default.
• W2913202387 title "Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis" @default.
• W2913202387 cites W1596144157 @default.
• W2913202387 cites W1802418114 @default.
• W2913202387 cites W1831639597 @default.
• W2913202387 cites W1875289986 @default.
• W2913202387 cites W1967395800 @default.
• W2913202387 cites W1968022798 @default.
• W2913202387 cites W1988935956 @default.
• W2913202387 cites W1993549674 @default.
• W2913202387 cites W1995624544 @default.
• W2913202387 cites W2000822251 @default.
• W2913202387 cites W2002853558 @default.
• W2913202387 cites W2017834980 @default.
• W2913202387 cites W2029694340 @default.
• W2913202387 cites W2032899417 @default.
• W2913202387 cites W2053085038 @default.
• W2913202387 cites W2055943806 @default.
• W2913202387 cites W2058430160 @default.
• W2913202387 cites W2064273742 @default.
• W2913202387 cites W2074198810 @default.
• W2913202387 cites W2095154908 @default.
• W2913202387 cites W2102955336 @default.
• W2913202387 cites W2104537698 @default.
• W2913202387 cites W2106925882 @default.
• W2913202387 cites W2106982390 @default.
• W2913202387 cites W2107830936 @default.
• W2913202387 cites W2111956140 @default.
• W2913202387 cites W2112873320 @default.
• W2913202387 cites W2130725052 @default.
• W2913202387 cites W2138045972 @default.
• W2913202387 cites W2163754536 @default.
• W2913202387 cites W2166176915 @default.
• W2913202387 cites W2168570141 @default.
• W2913202387 cites W2265207520 @default.
• W2913202387 cites W2275737843 @default.
• W2913202387 cites W2279822648 @default.
• W2913202387 cites W2319284081 @default.
• W2913202387 cites W2327872621 @default.
• W2913202387 cites W2397372388 @default.
• W2913202387 cites W2585274693 @default.
• W2913202387 cites W2750346694 @default.
• W2913202387 cites W2762165882 @default.
• W2913202387 cites W2792595686 @default.
• W2913202387 cites W2796196815 @default.
• W2913202387 cites W2848911503 @default.
• W2913202387 cites W4241470858 @default.
• W2913202387 cites W4251050426 @default.
• W2913202387 doi "https://doi.org/10.1371/journal.pone.0211888" @default.
• W2913202387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6368303" @default.
• W2913202387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30735536" @default.
• W2913202387 hasPublicationYear "2019" @default.
• W2913202387 type Work @default.
• W2913202387 sameAs 2913202387 @default.
• W2913202387 citedByCount "23" @default.
• W2913202387 countsByYear W29132023872019 @default.
• W2913202387 countsByYear W29132023872020 @default.
• W2913202387 countsByYear W29132023872021 @default.
• W2913202387 countsByYear W29132023872022 @default.
• W2913202387 countsByYear W29132023872023 @default.
• W2913202387 crossrefType "journal-article" @default.
• W2913202387 hasAuthorship W2913202387A5001455617 @default.
• W2913202387 hasAuthorship W2913202387A5002973930 @default.
• W2913202387 hasAuthorship W2913202387A5005473429 @default.
• W2913202387 hasAuthorship W2913202387A5008696378 @default.
• W2913202387 hasAuthorship W2913202387A5010143623 @default.
• W2913202387 hasAuthorship W2913202387A5011578742 @default.
• W2913202387 hasAuthorship W2913202387A5016033592 @default.
• W2913202387 hasAuthorship W2913202387A5025487051 @default.
• W2913202387 hasAuthorship W2913202387A5033799485 @default.
• W2913202387 hasAuthorship W2913202387A5061810491 @default.
• W2913202387 hasAuthorship W2913202387A5067286446 @default.
• W2913202387 hasAuthorship W2913202387A5069788866 @default.
• W2913202387 hasAuthorship W2913202387A5072574087 @default.
• W2913202387 hasAuthorship W2913202387A5077402434 @default.
• W2913202387 hasAuthorship W2913202387A5080555312 @default.
• W2913202387 hasAuthorship W2913202387A5084708203 @default.
• W2913202387 hasAuthorship W2913202387A5086479486 @default.

• next